Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance
Reference number: TA217
Published: 23 March 2011
Last updated: 20 June 2018

Appendix A - provisional matrix of stakeholders

Appendix A - provisional matrix of stakeholders

Appendix A - provisional matrix of stakeholders
23 April 2014
(97.94 Kb 28 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 23 April 2014